Dosage ; Orally: 4-16mg (HCL)
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ltd. | Ltd | mg | 30 | Tablet | per tablet | KES | |
| Ltd | (K) Ltd. | mg | 30 | Tablet | per tablet | KES |
| Bromhexine More info | |
|---|---|
| Mode Of Action | Ambroxol and carbocisteine possesses mucokinetic and secretolytic properties. Mucus secretion is normalized during their use in treatment. Cough and sputum volumes are significantly reduced. Bromohexine is a mucolytic agent only. |
| Drug Indication | Respiratory disorders associated with viscid or excessive mucus. |
| Precautions | Peptic ulcer |
| Side Effects | GI disturbances and transient rise in serum AST |
| Dosage | Orally: 4-16mg (HCL) |
| Special Information | It is a major metabolite of bromhexine |
| Pregnancy Category | Category A1: |
| Pregnancy Category Description | Drugs which have been taken by a sizeable number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. |
| Drug Category | DRUGS ACTING ON RESPIRATORY SYSTEM |
| Drug Sub-Category | Mucolytics |